Detalles de la búsqueda
1.
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.
J Am Soc Nephrol
; 27(7): 1902-10, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127187
2.
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
JAMA
; 317(2): 156-164, 2017 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28097356
3.
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
JAMA
; 317(2): 146-155, 2017 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28097355
4.
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 68(6): 873-881, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27646425
5.
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.
Am Heart J
; 170(2): 322-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26299230
6.
Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor.
Am J Nephrol
; 42(5): 379-88, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26684933
7.
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
N Engl J Med
; 361(21): 2019-32, 2009 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880844
8.
Albuminuria and racial disparities in the risk for ESRD.
J Am Soc Nephrol
; 22(9): 1721-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21868498
9.
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Am J Kidney Dis
; 58(5): 717-28, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21820220
10.
Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.
Nephrol Dial Transplant
; 26(5): 1583-91, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20861195
11.
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
Am J Kidney Dis
; 56(5): 861-71, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20692752
12.
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 54(1): 59-69, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19501439
13.
Chronic kidney disease and US healthcare resource utilization in a nationally representative sample.
Am J Nephrol
; 29(5): 473-82, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19039210
14.
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.
Bone
; 43(2): 343-347, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18544475
15.
Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with CKD and their families.
Nephrol Nurs J
; 34(2): 151-61, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17486946
16.
Assessment of time and practice resources required to provide weekly or monthly erythropoiesis-stimulating protein therapy to chronic kidney disease patients in the physician office setting.
J Manag Care Pharm
; 12(9): 714-25, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17249904
17.
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
J Am Heart Assoc
; 5(4)2016 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108247
18.
Prevalence and severity of chronic kidney disease and anemia in the nursing home population.
J Am Med Dir Assoc
; 11(1): 33-41, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20129213
19.
Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials.
Drugs Aging
; 26(8): 665-75, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19685932
20.
Association of anemia correction with health related quality of life in patients not on dialysis.
Curr Med Res Opin
; 23(12): 2997-3008, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17958944